CLU and acute kidney injury: However, in a recent study, Clusterin outperformed renal function indicators targeting both glomeruli and tubules in the assessment of subclinical AKI, indicating that it appears to be a promising marker of renal injury, covering both tubular and glomerular injury (Musiał et al., 2020), and thus Clusterin remains relevant for the detection of not only tubular but also glomerular injury significance.